
Granules India Limited has informed the Exchange about press release dated 18-Mar-2022 titled Granules India Receives Licences from MPP to Market Nirmatrelvir; Ritonavir
Filed with NSE ·

Granules India Limited has informed the Exchange about press release dated 18-Mar-2022 titled Granules India Receives Licences from MPP to Market Nirmatrelvir; Ritonavir
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India